;e majority of the new approaches more precisely attack
cancers than do traditional therapeutics, providing patients
with not just longer but also higher-quality lives.
It is clear that, through this fundamental research, which is
largely supported by the NIH and NCI, we have developed
a greater understanding of the processes by which cancer
starts, progresses, and results in disease. ;is knowledge
has yielded signi;cant progress in preventing, detecting,
diagnosing, and treating cancer. Continued progress,
therefore, will be made only through additional research,
and as such, it is imperative that the administration and
Congress support the primary federal agencies that support
this vital research, the NIH and NCI.